DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR ESTIMATION OF RIVAROXABAN USING HPLC-PDA IN HUMAN BLOOD PLASMA

  • Satyendra Yadav School of Pharmacy, Devi Ahilya Vishwa Vidyalaya, Indore (MP) India.
  • Nidhi Dubey School of Pharmacy, Devi Ahilya Vishwa Vidyalaya, Indore (MP) India.

Abstract

Rivaroxaban is oral anti-coagulant drug, used in the treatment of various blood disorders. A sensitive and accurate liquid chromatographic methodfor the quantification of rivaroxaban in human plasma was successfully developed. Protein precipitation was used for sample preparation. Quantification of analyte was achieved on phenomenexluna C8 (5µm x 25cm x 4.6mm i.d.) column using methanol:water:dimethyl sulfoxide (50:45:5, v/v/v) as mobile phase at a flow rate of 1ml/min. Detection was achieved at 252nm over the linearity concentration range of 5-40µg/ml. Retention time was found 6.2 min. The LOD and LOQ were found to be 1.5 µg/ml and 4.5 µg/ml, respectively.The developed method was validate as per US FDA guidelines. 

Downloads

Download data is not yet available.

Author Biographies

Satyendra Yadav, School of Pharmacy, Devi Ahilya Vishwa Vidyalaya, Indore (MP) India.

School of Pharmacy, Devi Ahilya Vishwa Vidyalaya, Indore (MP) India.

Nidhi Dubey, School of Pharmacy, Devi Ahilya Vishwa Vidyalaya, Indore (MP) India.

School of Pharmacy, Devi Ahilya Vishwa Vidyalaya, Indore (MP) India.

References

1. Rohde G, Determination of rivaroxaban--a novel, oral, direct Factor Xa inhibitor--in human plasma by high-performance liquid chromatography-tandem mass spectrometry, J Chromatogr B, 2008, 872, 43-50.
2. Kuhn J, Gripp T, Flieder T, Dittrich M, Hendig D, Busse J, UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and its Comparison with Functional Assays, PLoS ONE, 2015, 10 (12),78.
3. Celebier M, Reçber T, Koçak E, Altınöz, Kır S, Determination of Rivaroxaban in Human Plasma by Solid-Phase Extraction–High Performance Liquid Chromatography, J Chrom Sci, 2015, 7, 1-5.
4. Zhang W, Lou D, Zhang DT, Zhang Y, Huang HJ, Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC–MS/MS method, J Thromb Thrombolysis, 2016, 1-7.
5. Reddy GS, Prasad RSLN, Reddy LSK, Development and Validation of Hplc-Ms/Ms Method for Rivaroxaban Quantitation in Human Plasma Using Solid Phase Extraction Procedure, Orient J Chem, 2016, 32 (2), 1145-1154.
Statistics
138 Views | 68 Downloads
How to Cite
Yadav, S., & Dubey, N. (2017). DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR ESTIMATION OF RIVAROXABAN USING HPLC-PDA IN HUMAN BLOOD PLASMA. Journal of Drug Delivery and Therapeutics, 7(7), 123-125. https://doi.org/10.22270/jddt.v7i7.1608